SURESH RAMALINGAM, deputy director of Winship Cancer Institute of Emory University and assistant dean for cancer research in the Emory School of Medicine, was selected to hold the Roberto C. Goizueta Distinguished Chair for Cancer Research. The endowment was established to support a key leader in Winship’s lung cancer program. The position was previously held...
Early endpoints have the potential to get effective drugs to patients faster, but granting approval to drugs—even accelerated approval—comes with the risk that ineffective or even harmful drugs will be given to patients.
